The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults

09 Jan 20264 min read0 viewsINTERVENTIONAL Trial

GIST

RECRUITING · INTERVENTIONAL · TREATMENT study · Frailty · Phase 2 · Enrollment 60 · Sponsor: UConn Health

Clinical Editorial

Summary

ClinicalTrials.gov published a clinical update in Cardiology on 09 Jan 2026. The item focuses on The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults. Open the detail page to review the full original feed content.